What's in Thrombolex, Inc.'s pipeline?

Thrombolex, Inc. has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Thrombolex, Inc.'s portfolio?

Top competitors by shared drug class: All India Institute of Medical Sciences, Angde Biotech Pharmaceutical Co., Ltd., Beijing Chao Yang Hospital, Beijing Tiantan Hospital, Life Recovery Systems.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/thrombolex-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Thrombolex, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Thrombolex, Inc. pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
r-tPA	r-tPA	phase 3	Fibrinolytic agent / Thrombolytic	Plasminogen	Cardiovascular

Therapeutic area mix

Cardiovascular · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

All India Institute of Medical Sciences · 1 shared drug class
Angde Biotech Pharmaceutical Co., Ltd. · 1 shared drug class
Beijing Chao Yang Hospital · 1 shared drug class
Beijing Tiantan Hospital · 1 shared drug class
Life Recovery Systems · 1 shared drug class
Tasly Biopharmaceuticals Co., Ltd. · 1 shared drug class
The First Affiliated Hospital with Nanjing Medical University · 1 shared drug class
Tianjin Huanhu Hospital · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Thrombolex, Inc.:

Cite this brief

Drug Landscape (2026). Thrombolex, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/thrombolex-inc. Accessed 2026-06-10.